NeuroLight, Inc.Director Of Business Development
Jan. 2021 - Aug. 2024New York City Metropolitan AreaNeuroLight, Inc. has developed a novel and proprietary neuromodulation technology for transplanting mental statesTM. The process involves replicating brainwaves from a “donor,” who is in a desired mental state (such as sleep, the states of flow, hyper-focus, relaxation, etc.), to induce this state in the recipient. This revolutionary technology can be used to address diseases of the brain (such as sleep disorders, dementia, epilepsy, depression, anxiety, PTSD, phobias, addictions, ADHD, etc.) as well as for non-medical applications, such as emotional enhancement (for cinema, media, computer games, VR, advertising, etc.) and accelerated learning. The company is presently working on its first application to treat insomnia.